Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kneat.com Inc T.KSI

Alternate Symbol(s):  KSIOF

kneat.com, inc. develops and markets the Kneat Gx software-as-a-service (SaaS) platform. It designs, develops and supplies software for data and document management within regulated environments. The Company’s focus is to service the facilities, equipment and computer systems (CSV) validation market initially within the global life sciences industry. The Company’s product is Kneat Gx, a configurable, off-the-shelf application focused on validation lifecycle management and testing primarily within the life sciences industry. Kneat Gx provides a compliant digital solution that enables companies in the life sciences industry to become efficient and compliant with an automated process that has traditionally been manual, inefficient and paper-based. Its various validation processes include electronic logbook management, analytical instrument validation, utility and facility validation, process validation, method validation and equipment validation, cold chain validation, and others.


TSX:KSI - Post by User

Post by Possibleidiot01on Apr 27, 2023 4:30am
227 Views
Post# 35416279

Echelon -cantechletter.com

Echelon -cantechletter.com

kneat.com will help you beat the market, Echelon says

The share price for kneat.com (kneat.com Stock Quote, Charts, News, Analysts, Financials TSX:KSI) has been travelling sideways for over a year, but the company keeps racking up contract wins, including a recent Master Services Agreement (MSA) with one of the top 20 contract development and manufacturing organizations (CDMO) in the world. 

 

It’s that type of progress that’s keeping Echelon Capital Markets analyst Rob Goff bullish on the stock. Goff provided an update to clients on Wednesday where he reiterated a “Speculative Buy” rating and $4.20 target price on the stock, saying more and more wins show how kneat’s platform has become a go-to standard for compliance and validation software.

“We remain bullish about the Company’s organic growth as it completes its transition to a SaaS model. We believe KSI represents an attractive investment valued at 6.7x 2023 revenues and 10.6x EV/Gross Profits in the context of larger, slower growth peers Veeva Systems at 11.8x revenues and 16.2x EV/Gross Profits, and Aspen Technology, Inc at 12.0x revenues and 15.4x EV/Gross Profits,” Goff wrote.

A Canadian company with operational headquarters in Limerick, Ireland, kneat on Monday announced signing the MSA with a top 20 CDMO, saying the agreement is effective immediately, does not expire and allows the company to scale kneat across all of its business divisions and affiliates. Kneat said the global provider has 20,000 employees and over 100 facilities and a market size of US$160 billion in 2028 with an expected CAGR of ten per cent. 

Sabio"

“Today’s win affirms the progress we are making consolidating our leadership in validation for the life science space. We expect that more companies in the supply chain will look to benefit from the Kneat platform, which is proving to be an invaluable tool for automating processes that value data integrity,” said kneat CEO Eddie Ryan in a statement.

Goff is calling for kneat to generate full 2023 revenue of $34.0 million, good for a 44 per cent year-over-year increase and EBITDA of negative $4.9 million. For 2024, Goff is estimating $47.9 million in revenue and EBITDA of positive $0.7 million. At press time, Goff’s $4.20 target represented a projected one-year return of 63 per cent.

 

“KSI continues to highlight that full deployment across its current SaaS clients would support baseline revenues in excess of $50 million. We look for the $50 million benchmark to be increased reflecting new contract wins. We are optimistic that KSI will move to a target of $100 million in two years with the inclusion of adjacent markets where services are being developed. KSI puts its TAM at $700 million before allowing for adjacent markets where it has seen initial wins and where current R&D expenditures will broaden its service applications,” Goff said.


<< Previous
Bullboard Posts
Next >>